BrainSightAI, a deep-tech neuroscience startup from Bengaluru founded by Laina Emmanuel and Dr. Rimjhim Agrawal in 2019, is mapping the human brain using AI-powered connectomics—finding clinical applications beyond elite research labs. Their neuroinformatics platform, VoxelBox, analyzes fMRI and other imaging data to build personalized macro-scale neural connection maps, aiding neurosurgeons and psychiatrists in diagnosing and treating brain tumors, psychiatric disorders, and more.

Having secured a $5 million Pre-Series A round led by IAN Alpha Fund, BrainSightAI plans to expand across India’s Tier 1 and Tier 2 cities, pursue FDA approval for U.S. entry, and explore markets in Africa and Southeast Asia. A caregiver app is also in development to support families of patients.

BrainSightAI operates with over 40 hospitals, especially in neurosurgery and radiology, to integrate neural mapping into mainstream clinical workflows. By turning research-grade neuroimaging tech into scalable healthcare tools, they aim to democratize precision brain care—previously limited to institutions like Harvard and Stanford. Their platform is already influencing surgical planning and treatment strategies across neuro-oncological and neuropsychiatric conditions.

With a bold vision, advanced tech, and strategic partnerships, BrainSightAI is redefining how clinicians understand and treat brain disorders making detailed neural insights a clinical reality.